AR033862A1 - Formulacion de medicamento que contiene un agente agonista muscarinico - Google Patents
Formulacion de medicamento que contiene un agente agonista muscarinicoInfo
- Publication number
- AR033862A1 AR033862A1 ARP020100515A ARP020100515A AR033862A1 AR 033862 A1 AR033862 A1 AR 033862A1 AR P020100515 A ARP020100515 A AR P020100515A AR P020100515 A ARP020100515 A AR P020100515A AR 033862 A1 AR033862 A1 AR 033862A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation containing
- muscarinic agonist
- medicinal formulation
- agonist agent
- talsaclidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Formulación de medicamento que contiene talsaclidina 1', que consta de un núcleo que contiene la sustancia activa talsaclidina y un revestimiento de película que envuelve a éste núcleo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10106971A DE10106971A1 (de) | 2001-02-15 | 2001-02-15 | Arzneimittelformulierung die einen muskarinischen Agonisten enthält |
Publications (1)
Publication Number | Publication Date |
---|---|
AR033862A1 true AR033862A1 (es) | 2004-01-07 |
Family
ID=7674095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100515A Withdrawn AR033862A1 (es) | 2001-02-15 | 2002-02-15 | Formulacion de medicamento que contiene un agente agonista muscarinico |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1361871A2 (es) |
JP (1) | JP2004518710A (es) |
AR (1) | AR033862A1 (es) |
AU (1) | AU2002247705A1 (es) |
CA (1) | CA2434976A1 (es) |
DE (1) | DE10106971A1 (es) |
MX (1) | MXPA03007272A (es) |
UY (1) | UY27170A1 (es) |
WO (1) | WO2002064124A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE035990T2 (en) * | 2007-03-29 | 2018-05-28 | Daiichi Sankyo Co Ltd | Pharmaceutical preparation |
WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
WO2011115067A1 (ja) | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 抗凝固剤の溶出改善方法 |
KR101940840B1 (ko) | 2011-08-10 | 2019-01-21 | 다이이찌 산쿄 가부시키가이샤 | 디아민 유도체 함유 의약 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8817121U1 (de) * | 1988-11-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Quinuclidine |
AU5716898A (en) * | 1997-01-08 | 1998-08-03 | Warner-Lambert Company | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease |
WO1998046601A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Composition for treating pain |
WO1998046225A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Method for treating schizophrenia |
DE19851126A1 (de) * | 1998-11-06 | 2000-05-11 | Boehringer Ingelheim Pharma | Verwendung von Talsaclidin zur Behandlung der Schizophrenie |
-
2001
- 2001-02-15 DE DE10106971A patent/DE10106971A1/de not_active Withdrawn
-
2002
- 2002-02-09 AU AU2002247705A patent/AU2002247705A1/en not_active Abandoned
- 2002-02-09 MX MXPA03007272A patent/MXPA03007272A/es unknown
- 2002-02-09 CA CA002434976A patent/CA2434976A1/en not_active Abandoned
- 2002-02-09 JP JP2002563919A patent/JP2004518710A/ja active Pending
- 2002-02-09 EP EP02716755A patent/EP1361871A2/de not_active Withdrawn
- 2002-02-09 WO PCT/EP2002/001374 patent/WO2002064124A2/de not_active Application Discontinuation
- 2002-02-13 UY UY27170A patent/UY27170A1/es not_active Application Discontinuation
- 2002-02-15 AR ARP020100515A patent/AR033862A1/es not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2004518710A (ja) | 2004-06-24 |
WO2002064124A3 (de) | 2002-12-05 |
CA2434976A1 (en) | 2002-08-22 |
WO2002064124A2 (de) | 2002-08-22 |
AU2002247705A1 (en) | 2002-08-28 |
UY27170A1 (es) | 2002-09-30 |
MXPA03007272A (es) | 2003-12-04 |
DE10106971A1 (de) | 2002-08-29 |
EP1361871A2 (de) | 2003-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1183014E (pt) | Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor | |
DE60019693D1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
FR2774288B1 (fr) | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques | |
HUP0002797A2 (hu) | Késleltetett hatású gyógyszeradagoló rendszerek | |
IL166561A0 (en) | Pharmaceutical compositions | |
TNSN95076A1 (fr) | Forme de dosage ii d'unite multiple en comprime | |
FR13C0057I2 (fr) | Formulations d'aerosol a usage medical | |
CY1116429T1 (el) | Υμενιο για δερματικη και διαδερμικη χορηγηση δραστικων συστατικων | |
EP1078628A3 (en) | Multiple unit tableted dosage form | |
WO2002072033A3 (en) | Chronotherapeutic dosage forms containing glucocorticosteroid | |
ATE460921T1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
ES2192226T3 (es) | Composicion farmaceutica oral que contiene agentes activos antimicrobianos y pantoprazol de liberacion prolongada. | |
SE0003449D0 (sv) | Anticancer compositions | |
PL337794A1 (en) | Pharmaceutic agent for oral administration containing an active substance and cyclodextrin | |
BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
ATE469644T1 (de) | Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung | |
AR033862A1 (es) | Formulacion de medicamento que contiene un agente agonista muscarinico | |
DE60002089D1 (de) | Niedrig dosierte tabletten, und verfahren zur herstellung | |
ATE158172T1 (de) | Pulverförmige pharmazeutische zusammensetzung | |
ES2113985T3 (es) | Material de recubrimiento para formas medicamentosas de administracion oral. | |
FR2826367B1 (fr) | Nouveaux derives de [4-(4-cyanobenzoyl)phenyl] glycopyranoside, utilisation en tant que medicamment, procede d'obtention et compositions pharmaceutiques les contenant | |
RS52027B (sr) | Enterosolventne tablete sa acetilsalicilnom kiselinom | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |